Wisp vs Interlude: What Each One Actually Costs, and Which Fits Your Symptoms
Compare the product and the payment path
Affiliate link: we may earn a commission at no extra cost to you. Wisp's published starting price is lower, but confirm the exact product, quantity, and renewal total before paying.
Wisp vs Interlude splits by what you need. Wisp has the lower published cream starting price at $20, consult included, but does not disclose strength, quantity, or FDA status before checkout. Interlude starts at $84 for a 0.01% cream it identifies as an FDA-approved generic. For 10 mcg inserts, Interlude is the only one of the two.
What changes the Wisp vs Interlude verdict?
Answer: Three things can change the verdict: the true first payment, the exact product or form you want, and whether a local pharmacy can lower the medication cost. The $20-versus-$84 headline is only the first layer.
- Interlude's $39 cream is not $39 to start. Add its $45 one-time consult and its published starting outlay is $84. Wisp's prescription-care price starts at $20, with the consult included.[1][2][8][11]
- Interlude wins on disclosure, not automatically on long-term price. It publishes a 0.01%, 42.5 g cream that it identifies as an FDA-approved generic. Wisp does not publish its cream's strength, tube size, manufacturer, NDC, refill interval, or FDA status on the public product page.[8][1]
- The pharmacy route can beat Interlude's shipped cream. Interlude allows an outgoing prescription transfer, and Wisp can route a prescription to a local pharmacy. Insurance or a pharmacy discount can change the medication cost, but the exact result depends on what is prescribed and dispensed.[12][2][25]
Who is Wisp best for, and who should choose Interlude?
Answer: Wisp is the stronger starting point for the lowest published cream entry price, one-time ordering, pharmacy routing, or a separate systemic-menopause lane. Interlude is stronger for exact product disclosure, 10 mcg inserts, and a specialist vaginal-and-urinary model. Red flags make both the wrong first step.
Wisp is likely your better start if: you want the lowest published first payment for cream, you want a one-time purchase instead of mandatory auto-ship, you want local-pharmacy pickup, or you also need a separate systemic-menopause consult for symptoms such as hot flashes.[1][3]
Interlude is likely your better start if: you want the exact strength and quantity published before you pay, you want 10 mcg vaginal inserts, you want a service focused on vaginal and urinary symptoms, or you value one consult fee covering prescription refills and clinician messaging for up to a year.[8][9][12]
Neither one is your starting point if: you have bleeding after menopause, a new vulvar lump, sore, ulcer, or persistent white or thickened patch, fever with back or side pain, or symptoms that have not improved despite using treatment correctly. Neither company performs a physical examination. Jump to what to do instead →
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
What did The HRT Index actually verify?
Answer: We completed a documentation review of both providers' current product, pricing, intake, policy, and support pages on August 12, 2026. We also checked FDA and DailyMed labeling, professional guidance, and pharmacy-price benchmarks, then recalculated every cost and dose comparison shown here.
For Wisp, we read the estradiol product page, pricing page, menopause-consult page, how-it-works page, FAQ, and current Terms of Service. For Interlude, we read the homepage, pricing page, generic cream page, generic insert page, compounded cream page, FAQ, how-it-works page, refund policy, and Terms of Service.
We also checked the current FDA labeling-update roster, current DailyMed labeling for estradiol vaginal cream 0.01% and 10 mcg estradiol vaginal inserts, The Menopause Society's GSM guidance, the American Urological Association's recurrent-UTI guideline, and current pharmacy price guides.[18][20][21][22][24][25]
We did the arithmetic ourselves: first-payment totals, cost per insert, year-one cream scenarios, the first-box insert count, and the nominal amount of estradiol placed per maintenance week. Every formula is shown so you can check it.
What we could not verify: what Wisp's $20 buys. Its public page says “Starting at $20” and offers a one-time purchase or subscription, but it does not publish the exact formulation, strength, quantity, manufacturer, NDC, shipment interval, or renewal amount. Interlude identifies its generic cream and inserts as FDA-approved, but it does not publish the manufacturer or NDC that will be dispensed. We do not turn either blank space into a stronger claim than the pages support.[1][8][9]
This page is editorial research by The HRT Index Editorial Team under The HRT Index Verification Standard. It has not been reviewed by a clinician. It is education, not medical advice.
How do Wisp and Interlude compare at a glance?
Answer: Wisp wins the published first-payment comparison and purchase flexibility; Interlude wins product disclosure and offers 10 mcg inserts. Neither company includes a physical examination or routine lab bundle, and the local-pharmacy route can change the real medication cost.
| Decision fact | Wisp | Interlude |
|---|---|---|
| Main local-treatment offer | Prescription estradiol vaginal cream | A cream and 10 mcg inserts Interlude identifies as FDA-approved generics, plus a separate compounded cream |
| Treats hot flashes through this local product? | No. Wisp has a separate $99 systemic-menopause consult | No. Interlude's menopause offer is focused on vaginal and urinary symptoms |
| Cream headline price | Starting at $20; consult included | $39 first tube / $59 regular; consult separate |
| Consult fee | Included in prescription-care pricing | $45 one time |
| Published cream starting outlay | From $20; exact checkout total and shipment unknown | $84 before any taxes or checkout changes |
| 10 mcg vaginal inserts | Not listed on the Wisp estradiol page we verified | Yes; 18 inserts, labeled as a two-month supply |
| FDA-approved status disclosed before checkout | No public disclosure for this cream | Yes, provider-stated for the 0.01% generic cream and 10 mcg generic inserts; verify the dispensed label |
| Compounded option | The public estradiol page does not identify this cream as compounded or FDA-approved | Yes; Soothing Estradiol Cream is explicitly 503A compounded and not FDA-approved |
| Publishes exact cream strength + tube size | No | Yes; 0.01%, 42.5 g for the product Interlude identifies as an FDA-approved generic |
| Insurance for online service | Not billed to insurance | Not accepted |
| Insurance on medication | May apply at a local pharmacy | May apply after an outgoing prescription transfer |
| HSA / FSA | Most products eligible; confirm your plan | Accepted; confirm your plan |
| Routine lab bundle advertised | No | No |
| Physical examination included | No | No |
| Typical review timing | Most prescriptions sent within about 3 hours after intake and any required phone/video step | Provider message within 3–4 hours is the stated target |
| Recurring shipment choice | One-time purchase or subscription | Automatic shipments; postpone or cancel |
| Deadline to stop the next charge | At least 48 hours before renewal | Use at least two business days; the refund page separately says two days |
| If no medication is prescribed | Fee of up to $25 instead of the full consult price | Medication fee refunded; consult fee kept |
| State claim | Available / ships in all 50 states, subject to clinician licensure | Advertises availability in all 50 states, subject to clinician licensure |
| Do we earn a commission? | No | No |
How to read our labels:
- Verified — we read it on the company's live page and recorded the date.
- Company says — the company publishes it, but it is not independently auditable from the outside.
- Sources disagree — two pages publish different numbers. We show both.
- Confirm at checkout — the final number or product detail appears only after intake or payment steps.
The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.
Still deciding whether this is even a local-treatment problem? That is the fork this page cannot resolve for you, because it depends on where your symptoms are. Match your situation in Find My HRT Path →
What's the actual difference between Wisp and Interlude?
Answer: Interlude is a specialist telehealth service for vaginal and urinary symptoms, plus acute treatment for UTIs, BV, and yeast infections. Wisp is a broader women's telehealth platform with vaginal estradiol as one product and a separate systemic-menopause consult. The practical difference is scope, product disclosure, and how each company charges.[12][1][3]
Here is the thing nobody tells you when you land on these two websites: they look almost identical. Same soft colors. Same clinician-review promise. Same free-shipping language. Same friendly promise that you will not have to sit in a waiting room to talk about your own vagina.
But one is a specialist, and one is a department store.
Interlude — operated by GML Health, Inc. — is built around vaginal and urinary health. Its catalog includes a cream and inserts it identifies as FDA-approved generics, a compounded estradiol cream, nonhormonal products, and acute prescription treatment for UTIs, BV, and yeast infections.[8][9][12][10]
Wisp — operated by wisp, Inc. — sells across vaginal health, reproductive health, STI treatment, weight care, fertility, and menopause. Its vaginal estradiol cream sits in one aisle. Its separate $99 menopause consult, which may include estradiol patches, gels, oral estradiol, and progesterone options, sits in another. Medication from that consult is paid for separately at a local pharmacy.[3]
One more thing before we get to money
The Wisp and Interlude links on this page are unpaid. The HRT Index has an active affiliate relationship with Wisp elsewhere on the site, but the Wisp links in this article are direct editorial links and do not generate commission. Interlude links on this page are also direct and unpaid. Where we link an affiliate alternative, we label it at the link.[30]
That matters because the real answer here is not “Which button pays us?” It is “Which route leaves you with the right product, the right follow-up, and the fewest financial surprises?”
Which is cheaper, Wisp or Interlude?
Answer: Wisp has the lower published starting price for cream: from $20 with the consult included, versus Interlude's published $84 start for its $39 first tube plus $45 consult. That does not prove Wisp is cheaper over a year, because Wisp does not publish the quantity or refill interval. Insert pricing is a separate comparison.[1][2][8][11]
This is where most comparisons go wrong. They put $20 next to $39 and call it a day.
That is not the comparison. Wisp folds the consult into prescription-care pricing. Interlude charges it separately. The honest first number is what the company says will leave your bank account when you start — with anything still hidden labeled as hidden.
What you actually pay to start with cream
| Charge | Wisp | Interlude promotional price | Interlude regular price |
|---|---|---|---|
| Consult | Included | $45 | $45 |
| First cream shipment | From $20 | $39 | $59 |
| Published starting outlay | From $20 | $84 | $104 |
| Exact formulation and quantity disclosed? | No | Yes | Yes |
Interlude totals calculated by The HRT Index from its published prices on August 12, 2026. Wisp's exact checkout total, formulation, quantity, and renewal terms are not published; confirm before payment.
Wisp wins the first-payment comparison, and it is not close.
But Wisp's number comes with a blind spot: you still do not know how much cream $20 buys. Interlude makes you pay more up front and tells you exactly what ships — one 42.5 g tube of estradiol vaginal cream 0.01%, which it identifies as an FDA-approved generic and describes as a two-to-three-month supply.[8]
What about a full year of cream?
Interlude publishes enough for us to model it. Wisp does not.
Interlude's first generic cream tube is currently displayed at $39, with a regular price of $59. The product page says one 42.5 g tube lasts two to three months and refills are delivered every two months or at a frequency you select.[8]
Scenario A — one tube every two months:
$45 consult + $39 first tube + (5 × $59 refills) = $379 in year one
Scenario B — one tube every three months:
$45 consult + $39 first tube + (3 × $59 refills) = $261 in year one
These are cash-flow scenarios, not dosing instructions. Your prescription, actual use, refill timing, promotion terms, and any checkout change move the number.
For Wisp, we are not publishing a year-one number. Its page does not say what strength or quantity $20 buys, how many days it is intended to cover, or what the renewal amount will be. Multiplying an unknown by twelve is not math. It is a guess with a dollar sign on it.
Now the inserts, where the pricing gets messy
Interlude sells a 10 mcg estradiol vaginal insert that it identifies as an FDA-approved generic: 18 inserts in a box, described as a two-month supply. Its homepage says “starting at $89,” while the product page displays $109 with $129 crossed out. That means the company currently publishes three price surfaces for the same 18-count box.[7][9]
| Source captured August 12, 2026 | Quantity | Published price | Cost per insert |
|---|---|---|---|
| Interlude homepage | 18 | $89 | $4.94 |
| Interlude product page | 18 | $109 | $6.06 |
| Interlude crossed-out regular price | 18 | $129 | $7.17 |
| Drugs.com price guide | 18 | $134.39 | $7.47 |
| GoodRx published generic coupon example | 8 | $37.83 | $4.73 |
The last row is not a guaranteed local quote. GoodRx pricing changes by pharmacy, ZIP code, quantity, and coupon availability. But it proves something important: Interlude can beat a standard price guide and still lose to a local coupon. The draft claim that Interlude beats every pharmacy cash price was too broad.[25][26]
The correct decision is simple:
- Compare Interlude's final checkout price for 18 inserts.
- Ask your pharmacy for the cash, insurance, and coupon price for the exact 10 mcg product and quantity prescribed.
- Compare total box cost, not a headline “as low as” number from a different quantity.
We are not publishing a year-one insert total until Interlude's own $89 / $109 / $129 conflict resolves.
One thing to check on your first insert box
Interlude's current dosing page says one 10 mcg insert nightly for two weeks, then one insert twice weekly. The first 14 days therefore use 14 inserts, leaving four inserts in an 18-count box.[9][21]
That is enough for the loading phase plus two maintenance weeks — not the loading phase plus a full additional two months of twice-weekly maintenance.
To be fair, Interlude already knows this. Its FAQ tells patients who need more medication while getting started to move the refill date earlier.[12]
So this is not a trap. It is a question to ask before paying:
“Does my first 18-count box cover the two-week starter phase, what date will the next box ship, and what will that early refill cost?”
★ The one thing we'd want you to know before you pay Interlude
Interlude's $39 cream headline is not what you pay to start. Its consult is $45, charged separately, so the provider-published starting outlay is $84, not $39. If the lowest possible entry cost is what matters most, Wisp's from-$20 door is the cheaper door, and you should walk through it — after confirming what product and quantity that price buys.
But here is why Interlude's $45 is not automatically a rip-off.
Wisp bundles clinician review into the product price. That is clean and cheap on day one. Interlude charges once up front, and its pages say that fee covers the prescription process for up to a year, with clinician messaging included. After the first payment, the recurring shipped cost is the treatment price, not another monthly visit fee.[11][12]
Both structures are defensible. Just pick yours on purpose.
Decided on cream and want the lowest published starting price? → See Wisp's current estradiol cream price and confirm the exact product at checkout (affiliate link; we may earn a commission at no extra cost)
Decided on 10 mcg inserts? → See Interlude's current insert page, then compare the checkout total with your pharmacy (direct editorial link)
Can you pay once and use your own pharmacy?
Answer: Yes. Interlude says it can transfer a prescription out to a local pharmacy on request, while Wisp is built to route a prescription to a local pharmacy. That can lower the medication cost through insurance or a discount card. It does not guarantee the same manufacturer, price, or product without checking the actual prescription and pharmacy label.[12][2]
Nobody is hiding this, exactly. It is just not the first comparison most readers make.
Interlude's FAQ says you can request an outgoing transfer by contacting support. Wisp's pricing page makes local-pharmacy pickup part of the standard flow and says eligible insurance can apply to the pharmacy cost.[12][2]
So let us price the cream route using a current cash-price benchmark.
Drugs.com's August 2026 price guide lists generic estradiol vaginal cream 0.1 mg/g, 42.5 g, from $37.76. Pharmacy prices vary and are not guaranteed.[25]
| Cream path | Year-one scenario | What the number includes |
|---|---|---|
| Interlude shipped, one tube every 2 months | $379 | $45 consult, first $39 tube, five $59 refills, shipping |
| Interlude shipped, one tube every 3 months | $261 | $45 consult, first $39 tube, three $59 refills, shipping |
| Interlude consult, then local pharmacy | About $196–$272 | $45 consult plus four to six 42.5 g tubes at the $37.76 price-guide benchmark |
| Wisp shipped | Not publishable | Quantity and refill interval not disclosed |
| Wisp, prescription sent to pharmacy | Varies | Wisp fee plus the pharmacy's cash, coupon, or insurance price |
The local-pharmacy range is a transparent scenario, not a promise: $45 + (4 × $37.76) = $196.04; $45 + (6 × $37.76) = $271.56.
On Interlude's cream, paying once and filling locally can beat Interlude's own shipped plan. Compared with the matching refill scenarios above, the modeled saving is about $65 to $107 in year one before any lower insurance copay.
Three honest catches:
- It only works one direction. Interlude says it cannot accept a prescription transferred in. It can issue a new prescription and can help transfer one out.[13]
- You lose the convenience. You give up the automatic delivery, shipment reminders, and no-pharmacy-trip part. Some women will happily pay for that.
- Ongoing messaging after transfer is not explained. The public FAQ does not say whether clinician access continues unchanged if you stop buying shipped medication. Ask before transferring.
Wisp has a version of this too, and it is more visible: the company says it can send a prescription to a local pharmacy, where eligible insurance or its GoodRx discount card may affect the medication cost.[2]
The rule underneath all of this is simple: the clinician-review charge and the medication charge are two different money questions. Keeping them separate is how you stop overpaying.
Your four-path cost worksheet
Before paying, write down these four totals:
| Path | What to enter |
|---|---|
| Wisp shipped | Today's complete charge + exact quantity + renewal amount + renewal date |
| Wisp pharmacy pickup | Wisp charge + pharmacy cash/copay/coupon price |
| Interlude shipped | $45 consult + first shipment + every refill scheduled in the next 12 months |
| Interlude transfer-out | $45 consult + local-pharmacy cash/copay/coupon price × expected fills |
Do not compare until all four rows use the same time period and the same prescribed product.
Need the route decision before the arithmetic? Use Find My HRT Path to sort local treatment, systemic care, insurance, and in-person red flags →
Cream or inserts — which vaginal estrogen should you pick?
Answer: Cream offers placement flexibility, including the vulva and vaginal opening when your prescriber directs it, while inserts provide a fixed 10 mcg dose with less measuring and mess. The products contain very different nominal amounts of estradiol per maintenance week, but those milligram totals do not establish equivalent absorption or interchangeable dosing.[22][9][8]
This is the part we could not find assembled anywhere else, so we built it.
How much estradiol is placed per maintenance week?
Calculated by The HRT Index from each published concentration and Interlude's published maintenance instructions, August 12, 2026.
| Product | Published strength | Published maintenance use | Nominal estradiol placed per week | Regulatory status |
|---|---|---|---|---|
| Estradiol vaginal cream 0.01% | 0.1 mg per gram | 1 g, 1–3 times weekly | 0.1–0.3 mg | FDA-approved generic, per Interlude; verify dispensed label |
| Soothing Estradiol Cream | 0.03 mg per gram | 1 g, 1–3 times weekly | 0.03–0.09 mg | Compounded; not FDA-approved |
| Estradiol vaginal insert 10 mcg | 0.01 mg per insert | 1 insert twice weekly | 0.02 mg | FDA-approved generic, per Interlude; verify dispensed label |
Read this as nominal amount placed, not amount absorbed and not clinical equivalence. Cream and inserts have different formulations, placement, and pharmacokinetics. You cannot use this table to convert your own dose or switch products without a prescriber.
Three things fall out of that table.
The insert is the most precise option on this page. One insert is one fixed 10 mcg unit. There is no gram line to fill and no cream left on an applicator.
The cream is more flexible and less precise. The Menopause Society describes low-dose local estrogen applied to the vulva and vagina, and Interlude says its generic cream may be used with the applicator or fingertip according to the clinician's instructions.[22][8]
Interlude's compounded cream is about one-third the concentration of its FDA-approved 0.01% generic cream, and it currently costs $10 more at both the promotional and regular price points. That is a product distinction, not a reason to improvise the dose. The compounded formula has different ingredients, different instructions, and no FDA premarket approval.[10][16]
What about the ring?
Neither company currently advertises an estradiol vaginal ring. Interlude's education pages discuss rings, but its current shop sells the cream and insert forms. Wisp's verified menopause and vaginal-dryness pages do not list a ring.
That gap matters because Estring was the only topical vaginal estrogen in the FDA's first February 2026 labeling-update group. We come back to that below.[18]
For a broader guide to creams, tablets, and rings, see vaginal estrogen for menopause symptoms.*
Do you need vaginal estrogen, full hormone therapy, or both?
Answer: Vaginal estrogen is local treatment for vulvar, vaginal, and urinary symptoms. Systemic hormone therapy is used for body-wide menopause symptoms such as hot flashes and night sweats. Some women use both when systemic treatment does not fully resolve local symptoms. Interlude handles the local lane; Wisp offers the local product and a separate systemic-menopause consult.[19][22][3]
This is the fork that decides whether this comparison even applies to you.
| Where your symptoms are | What usually fits the question | Can Interlude help? | Can Wisp help? |
|---|---|---|---|
| Vulva, vagina, or urinary tract only — dryness, burning, painful sex, urgency, recurrent UTIs | Local GSM treatment | Yes | Yes |
| Body-wide only — hot flashes, night sweats, sleep disruption linked to vasomotor symptoms | Systemic-menopause evaluation | No systemic program advertised | Yes, through a separate $99 consult; medication extra |
| Both | A clinician may consider local treatment, systemic treatment, or both | Local lane only | Both lanes are available, but they are separate purchases |
The Menopause Society's guidance makes the split plainly: systemic estrogen used for hot flashes can also help vaginal symptoms, but some women still need local treatment; when symptoms are only vaginal, low-dose vaginal treatment is recommended.[22]
These two companies are not necessarily either/or. If you already have a systemic-HRT prescriber, Interlude could serve the local-treatment lane. If you want one company to evaluate both lanes, Wisp's broader menopause program is the only one of these two that advertises systemic prescriptions.
If you have hot flashes or night sweats too, Interlude cannot resolve the whole problem. Wisp can evaluate systemic options, and an insurance-billed menopause clinic may be cheaper than paying cash in two separate lanes.
Midi Health is available in all 50 states and says it is in network with most PPO plans, with plan-specific coverage. Medicare does not cover Midi visits, although Medicare beneficiaries may use Midi as self-pay and cannot submit claims. Midi says it cannot treat Medicaid or Medi-Cal patients even as self-pay patients. (Affiliate link — we may earn a commission.)[28]
Are Wisp and Interlude legitimate?
Answer: Both operate as prescription telehealth platforms with licensed clinician review, both require a prescription, both display LegitScript certification, and both publish corporate and policy information. Legitimate does not mean identical. The product disclosure, payment structure, subscription design, and refund terms differ materially.[1][5][13][11]
That is the real question underneath “Wisp vs Interlude.” Not just which is better — is this allowed to be this easy?
Here is the checklist we use.
| Legitimacy test | Wisp | Interlude |
|---|---|---|
| Licensed clinician review | Yes | Yes |
| Prescription required | Yes | Yes |
| LegitScript displayed | Yes | Yes |
| Corporate identity published | wisp, Inc. | GML Health, Inc. |
| Exact generic cream specification before checkout | No | Yes — 0.01%, 42.5 g, ingredient list |
| Refund / subscription terms published | Yes | Yes |
| Human support channel | Email and patient portal | Email, phone, account messaging |
| Physical examination | No | No |
Both pass the legitimacy test. But look at the row where they split.
Interlude publishes the exact strength, exact tube size, inactive ingredients, and its FDA-approved-generic designation before payment. Wisp's public estradiol page gives the starting price, product category, eligibility sentence, latex-condom warning, and purchase modes — but not the strength, quantity, manufacturer, NDC, or FDA status.[8][1]
That is not proof that Wisp's product is bad. It is proof that you should not claim to know what it is until checkout or the pharmacy label tells you. On price transparency, Interlude is doing this part better.
One sequencing detail that surprises people
Interlude takes payment before the medical questionnaire and clinician review. Its product and FAQ pages state that checkout comes first, then the assessment, then the provider decision.[8][12]
Wisp does not publish the same sequence. Its Terms say a prescription product cannot be purchased until the consultation is completed, a licensed practitioner determines the product is appropriate, and a prescription is written. The Terms also say you review the fees before payment. If no treatment can be prescribed, Wisp says the provider-review charge is reduced to a fee of up to $25.[4][6]
That payment order is why the refund policy matters. We cover it in the cancellation section.
Is the medicine FDA-approved or compounded?
Answer: Interlude clearly sells both categories. Its estradiol vaginal cream 0.01% and 10 mcg inserts are marketed as FDA-approved generics. Its Soothing Estradiol Cream is made by a 503A compounding pharmacy and is not FDA-approved. Wisp's public estradiol page does not disclose the status of the cream, so the final product must be confirmed at checkout or on the pharmacy label.[8][9][10][1]
This is the single most important distinction on the page, so we are going to be precise about it.
FDA-approved generic
An FDA-approved generic goes through an FDA approval pathway and must meet FDA requirements for strength, dosage form, route, quality, labeling, and bioequivalence to its reference product. Interlude explicitly places its 0.01% cream and 10 mcg inserts in this category.[17][8][9]
Compounded
A compounded drug is prepared by a pharmacy for a prescription need. The FDA states that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness, or quality before they are marketed.[16]
That is a regulatory fact, not an accusation. Compounding can be appropriate when a patient's medical need cannot be met by an available FDA-approved drug. It is still a different category and cannot be presented as equivalent to an FDA-approved generic.[16]
What is in Interlude's compounded cream?
Interlude's current product page says its Soothing Estradiol Cream is freshly compounded at a U.S. 503A pharmacy with PCAB accreditation. The current tube is 30 g, not 32 g. The published formula is:[10]
- Estradiol 0.003%
- Hyaluronic acid 0.5%
- Aloe 0.5%
- Vitamin E 1%
- A cream base containing polyethylene glycol and mineral oil
The current published price is $49 for the first tube and $69 regular, plus the separate $45 consult.[10][11]
Three things to hold onto:
- Compounded is not a synonym for weaker, stronger, safer, more natural, or gentler. It means the product is compounded rather than FDA-approved.
- It is not equivalent to the FDA-approved 0.01% cream. The concentration, inactive ingredients, regulatory review, dispenser, and instructions differ.
- It has a lower estradiol concentration and a higher published price than Interlude's FDA-approved generic cream. That does not tell you which prescription fits you; it tells you not to confuse the two product cards.
We are excluding one of our own affiliates here, by name
We earn a commission from Inner Balance, which sells Oestra, a compounded prescription vaginal cream containing estradiol and progesterone. We are not recommending it as a substitute for the FDA-approved generic products in this comparison. It is compounded, not FDA-approved, and cannot be treated as interchangeable with the products whose FDA labeling and fixed strengths we can verify.[29]
We are telling you that because it is the clearest proof we can offer that the category line above was not drawn around a payout.
What to do: ask for the full product name, strength, dosage form, manufacturer or compounding pharmacy, quantity, and refill date. Then read the pharmacy label when it arrives. The label is the answer — not the mood board on the website.
Is vaginal estrogen safe, and what changed in 2026?
Answer: In February 2026, the FDA approved labeling changes for six menopause hormone products. Estring was the only topical vaginal estrogen in that first group. The current DailyMed labels we checked for estradiol vaginal cream 0.01% and 10 mcg estradiol vaginal inserts still display boxed warnings. Interlude's generic products are in those unchanged dosage-form categories.[18][20][21]
You have probably seen a headline about the boxed warning. Both company sites discuss it. Here is what actually changed.
| What happened | What it means here |
|---|---|
| FDA requested broader menopause-label updates in November 2025 | The review was real and applied across multiple hormone-therapy categories |
| FDA approved the first six updated labels on February 12, 2026 | The first completed group was limited, not every estrogen product at once |
| The only topical vaginal estrogen listed in that group was Estring | The ring's label changed |
| Current DailyMed labels for estradiol vaginal cream 0.01% and 10 mcg inserts still show boxed warnings | Interlude's generic cream and insert pages should not be described as already relabeled |
| Wisp does not disclose its exact cream on the public page | Check the dispensed label instead of assuming which warning applies |
This does not mean the underlying clinical evidence suddenly changed in February. It means FDA labeling changes are product-specific and are being completed product by product.
The Menopause Society's current GSM patient guidance describes low-dose local estrogen as an effective treatment applied to the vulva and vagina, with improvement usually occurring over weeks or months. The same guidance says that when vaginal symptoms are the only symptoms, low-dose vaginal treatment is recommended.[22]
The FDA's February 2026 consumer guidance also separates topical vaginal estrogen from systemic hormone therapy rather than treating them as one route.[19]
The carve-out that matters: if you have a history of breast or uterine cancer, or you take an aromatase inhibitor, the decision belongs in shared decision-making with your treating clinicians and, where relevant, your oncology team. The Menopause Society says low-dose vaginal estrogen may be considered in selected patients in collaboration with their clinicians.[22]
For a broader explanation of the local-treatment pathway and the questions to bring to your clinicians, see our vaginal estrogen guide.
Where Interlude's FAQ is stale
Interlude's FAQ is dated February 10, 2025 and still says advocates have been lobbying the FDA to remove vaginal-estrogen warnings. That sentence predates the November 2025 FDA request and the February 2026 first labeling approvals.[12][18]
The site's newer product copy acknowledges that the FDA initiated changes, but it still speaks broadly. The accurate version is narrower: the first approved group included Estring; the current generic cream and 10 mcg insert labels we checked still carry boxed warnings.
Does vaginal estrogen help recurrent UTIs?
Answer: Vaginal estrogen is an established prevention option for recurrent UTIs in peri- and postmenopausal women when clinically appropriate. The American Urological Association guideline says clinicians should recommend vaginal estrogen therapy to reduce the risk of future UTIs in this group. It does not treat an active infection already causing symptoms.[24]
If you are here because you keep getting UTIs and someone mentioned estrogen, you are not chasing a fringe theory. It is in the guideline.
The practical distinction is the one that matters:
- Prevention: local estrogen may reduce future recurrences over time.
- Active symptoms now: you need clinical evaluation. An active bacterial infection may require antibiotics.
- Fever, chills, nausea, vomiting, or back/side pain: seek prompt care because those can be signs of a kidney infection.[27]
Both Wisp and Interlude sell separate acute-UTI care. That does not turn vaginal estrogen into an antibiotic, and it does not make a subscription the right response to a possible kidney infection.
How hard is it to cancel, and what if you don't qualify?
Answer: Wisp lets you choose a one-time purchase or subscription and requires cancellation at least 48 hours before renewal. Interlude uses automatic shipments that cannot be switched off; you may postpone or cancel. Its Terms require cancellation at least two business days before the next shipment, while its refund page says two days. Neither company refunds dispensed prescription medication as a normal return.[1][6][12][15][14]
This is the section that matters most if your real fear is getting stuck.
| Policy | Wisp | Interlude |
|---|---|---|
| Order structure | One-time purchase or subscription | Subscription with automatic shipments |
| If no treatment is prescribed | Fee of up to $25 instead of full consult price | Medication fee refunded; $45 consult fee kept |
| Prescription medication already dispensed | Sales final except listed fulfillment problems | No refunds; defective products reported within two weeks may be replaced |
| Can recurring shipment be switched off while keeping account active? | Not relevant to one-time orders; subscription can be canceled | No. Postpone a shipment or cancel all shipments |
| Deadline to stop next charge | At least 48 hours before refill/renewal period | Use two business days to satisfy the stricter published term |
| How to cancel | Patient portal or support email | Payments page → “I want to cancel” |
| Prescription transfer | Can route to local pharmacy | Can transfer out; cannot accept a transfer in |
Read that auto-ship row again, because it is Interlude's own published position. There is no permanent “turn off shipments but keep everything else unchanged” switch. You postpone, or you cancel all shipments.[12]
There is a benefit to that design: automatic refills remove one administrative step from a treatment that may continue long term. There is also a cost: the default is another charge and shipment. That should be a choice you made, not one you discovered.
Interlude's refund wording conflicts with itself
Interlude's pricing page says that if you do not qualify, “we will refund your payment.” Its dedicated refund page is more specific: the medication fee is refunded, and the consultation fee is not.[11][14]
For budgeting, assume the $45 consult is kept if no medication is prescribed.
Before you enter a card, get these six answers
- What exactly is charged today, in total?
- What product, strength, manufacturer, and quantity will be prescribed or shipped?
- What date does it renew, and for how much?
- What fee remains if no medication is prescribed?
- Can the refill date be moved, and how far?
- Does the promotion apply only to the first shipment?
Screenshot the answers. Two minutes now beats an email chain in November.
Does Wisp or Interlude take insurance, HSA, or FSA?
Answer: Neither company bills the online service to health insurance. Wisp says eligible insurance may apply when a prescription is filled at a local pharmacy. Interlude accepts HSA/FSA and permits an outgoing pharmacy transfer, where insurance may apply to the medication. Both advertise nationwide access, but prescribing still depends on a clinician licensed in your state.[2][12][13]
| Access question | Wisp | Interlude |
|---|---|---|
| Insurance for online service | Not billed | Not accepted |
| Insurance on medication | May apply at local pharmacy | May apply after transfer to local pharmacy |
| HSA / FSA | Most products eligible; plan rules apply | Accepted; plan rules apply |
| Shipping | Free to all 50 states | Free for vaginal-estrogen products |
| Local same-day pickup | Yes, if prescribed and locally available | Acute medications; vaginal-estrogen products normally ship |
| State claim | Available / ships in all 50 states | Advertises all 50 states |
| Routine lab bundle | Not advertised | Not advertised |
On states: a nationwide company claim and a prescriber licensed for your exact location on the day you order are not identical facts. Wisp and Interlude both describe state-licensed clinician review. Confirm eligibility before paying if your state or video-visit rules are a concern.[4][13]
On labs: neither public product flow includes a routine hormone-testing bundle. That is not automatically a defect. GSM is evaluated from symptoms and, when needed, a physical examination; routine hormone numbers are not what distinguishes dryness from a vulvar skin condition. The limitation is the missing exam, not a missing “hormone panel.”[22][1][8]
What do the reviews actually tell you?
Answer: Wisp's own estradiol page currently displays a 4.3/5 company rating. Interlude's product pages display an “Excellent” Trustpilot label and explicitly call their on-page carousel “favorite reviews.” Those surfaces are not comparable datasets. Reviews can illuminate shipping, support, and billing; they cannot establish that vaginal estrogen will work for you.[1][8]
We are deliberately not turning different review pools, capture dates, and display methods into a fake score.
Reviews are useful for:
- Whether the package arrived when promised
- Whether support replied
- Whether a cancellation was processed
- Whether a damaged product was replaced
- Whether the amount charged matched the amount shown
Reviews are not reliable evidence for:
- Medical efficacy for your body
- Safety for your history
- Whether a compounded formula is equivalent to an FDA-approved product
- Whether a symptom that needs an exam can be diagnosed through a form
That is why this page uses provider pages for commercial facts and FDA, guideline, label, and professional-society sources for medical claims.
Where do Wisp's and Interlude's own numbers not line up?
Answer: We found six places where a company leaves a material blank or publishes different numbers across its own pages. We show the conflict instead of quietly choosing the figure that makes the cleaner story.
| What we found | What it means for you |
|---|---|
| Interlude's insert appears as “starting at $89” on its homepage and $109 with $129 crossed out on the product page. | Treat checkout as authoritative and screenshot it. Do not budget from one page alone. |
| Interlude says the consult covers 7 refills or one year near the product CTA, then 6 refills or one year in its pricing copy and FAQ. | The one-year period is consistent; the refill count is not. Ask which applies to your order. |
| Interlude's Terms require two business days to cancel, while the refund page says two days. | Use the stricter two-business-day deadline. |
| Interlude's pricing page says a declined patient gets “your payment” refunded, while its refund policy keeps the consult fee. | Budget as if the $45 consult is nonrefundable. |
| Wisp publishes “Starting at $20” without the strength, quantity, manufacturer, NDC, refill interval, or renewal amount. | This is why no Wisp annual total or FDA status is claimed here. Confirm before paying. |
| Wisp's eligibility sentence reads “40+, breastfeeding, and at least one year postpartum.” | The grammar is ambiguous. Do not turn it into an “and” or “or” rule on Wisp's behalf; answer the intake questions and confirm eligibility. |
None of these is automatically a scandal. Websites drift. Promotions change. Different teams update different pages. But every one is a place where a reader could budget wrong or assume the wrong product, so every one belongs on the page.
When is online care the wrong first step?
Answer: Neither company performs a physical examination, and GSM symptoms can overlap with infection, vulvar skin disease, pelvic-floor pain, and cancer-related warning signs. Bleeding after menopause needs evaluation. A persistent vulvar lesion or symptoms that do not improve with treatment also need someone who can examine the tissue.[22][20]
We have spent this whole page helping you buy something. This section is where we tell you not to.
Go to a clinician, not a checkout, if you have:
- Any bleeding after menopause. Most causes are not cancer, but postmenopausal bleeding is evaluated because it can be a warning sign, and current estradiol labels specifically call for diagnostic evaluation of unexplained persistent or recurring bleeding.[20]
- A new lump, sore, ulcer, or persistent white or thickened patch on the vulva.
- Symptoms that have not improved after several weeks to about three months of correct use, or symptoms that are getting worse. The Menopause Society notes that non-menopause conditions can cause similar vulvar and vaginal symptoms.[22]
- Fever, chills, nausea, vomiting, or back/side pain with urinary symptoms. Those can signal a kidney infection and need prompt care.[27]
- A history of breast or uterine cancer, or current aromatase-inhibitor treatment, without a plan from your treating clinicians. This is not an automatic no; it is a shared-decision pathway.[22]
Both services are largely asynchronous. A licensed clinician reads your history and follows up by message, phone, or video when needed. That works for many straightforward prescription questions. It does not replace looking at a lesion, evaluating unexplained bleeding, or examining pain that does not fit the expected pattern.
If what you need is an actual exam, Sesame lets eligible cash-pay patients search in-person and video OB/GYN appointments with upfront prices. Availability and price depend on your location. Sesame's Terms say Medicare, Medicaid, TRICARE, and other federal health-care-program beneficiaries cannot use the service. (Affiliate link — we may earn a commission.)[31]
So which should you choose: Wisp or Interlude?
Answer: Choose Wisp for the lower published cream starting price, one-time-purchase option, local-pharmacy routing, or a separate systemic-menopause lane. Choose Interlude when exact product disclosure, a specialist local-care model, or 10 mcg inserts matters more. For the lowest long-term cost, compare the prescribed product at your pharmacy. Red flags override every price comparison.
| If this is you | Start here | Why |
|---|---|---|
| You want cream and the lowest published first payment | Wisp | From $20 with clinician review included, versus Interlude's $84 published start |
| You refuse to pay before knowing the strength and tube size | Interlude generic cream | Publishes 0.01%, 42.5 g, ingredients, and FDA-approved generic status |
| You want 10 mcg inserts | Interlude, then compare your pharmacy | Interlude sells them; Wisp's verified estradiol page does not |
| You want the lowest modeled year-one Interlude cream cost | Interlude consult, then local pharmacy | The price-guide scenario is about $196–$272, subject to actual pharmacy pricing |
| You want to use insurance on medication | Wisp local-pharmacy route or Interlude transfer-out | Both can separate telehealth from pharmacy payment |
| You want zero automatic shipments | Wisp one-time purchase | Interlude's shipments are automatic until postponed or canceled |
| You have hot flashes or night sweats too | Wisp's separate menopause consult or an insurance-billed clinic | Interlude does not offer systemic menopause HRT |
| You have Medicare | Compare local covered care with cash-pay options | Midi permits self-pay for Medicare beneficiaries but does not accept Medicare or allow claims |
| You have Medicaid or Medi-Cal | Use an eligible local or plan-covered clinician | Midi states it cannot treat Medicaid or Medi-Cal patients, even as self-pay |
| You have a history of hormone-sensitive cancer | Your treating team first | Shared-decision pathway, not a checkout-only decision |
| You have any red-flag symptom | An in-person clinician | Neither company examines you |
| You cannot tell which lane you are in | Find My HRT Path | Symptoms, history, route, insurance, and state decide this |
If cream fits and you want the cheapest published way in: → Check Wisp's estradiol eligibility, then confirm the exact product, quantity, and renewal total (affiliate link; we may earn a commission at no extra cost)
If exact product disclosure or inserts matter more: → Check Interlude's current product page and final checkout price (unpaid link)
If you need local and systemic menopause care under commercial insurance: → Check your plan and eligibility with Midi Health (direct editorial link; Medicare is self-pay only and not claimable, and Medicaid/Medi-Cal patients are not eligible)
What else should you know about Wisp vs Interlude?
Answer: The remaining decision points are legitimacy, insurance, cancellation, treatment timing, progesterone, state access, and the product details hidden until checkout. These answers are short by design so you can resolve the last question without starting another search.
Is Interlude legit?
Yes. Interlude is operated by GML Health, Inc., requires clinician review and a prescription, displays LegitScript approval, and says prescribing clinicians are licensed in the patient's state. Its generic cream and insert pages publish detailed product specifications. Legitimacy does not erase the separate $45 consult, automatic shipments, or refund limits.[11][13][14]
Who owns Interlude?
Interlude's site identifies GML Health, Inc. as the operating company.[15]
Does Wisp sell vaginal estrogen?
Yes. Wisp sells a prescription product called Estradiol Vaginal Cream, starting at $20, as a one-time purchase or subscription. The public page does not disclose the formulation, strength, quantity, manufacturer, NDC, or FDA status, so confirm those details before payment or on the pharmacy label.[1]
Is Interlude cheaper than Wisp?
Interlude is not cheaper on the published first payment for cream: its promotional start is $84 after the $45 consult, versus Wisp starting at $20 with the consult included. Wisp's annual cost cannot be compared because its public page does not disclose the quantity or refill interval. Insert pricing depends on Interlude's conflicting price surfaces and your local pharmacy price.
Does Interlude take insurance?
No. Interlude says it does not accept insurance. It accepts HSA and FSA cards and says it can transfer a prescription to a local pharmacy on request, where insurance may apply to the medication.[12]
Does Wisp take insurance?
Wisp does not bill its online prescription service to insurance. It says eligible insurance can be applied to medication costs when you choose local-pharmacy pickup.[2]
Can I use HSA or FSA funds?
Both companies say they accept HSA/FSA payment for eligible care or products, subject to your plan's rules.[2][12]
How do I cancel Interlude?
Go to the Payments page in your Interlude account and select “I want to cancel.” Interlude's Terms require cancellation at least two business days before the next shipment to avoid the charge. Its refund page says two days, so use the stricter business-day deadline.[12][15][14]
How do I cancel Wisp?
Use the patient portal or contact Wisp support. Wisp's Terms require cancellation at least 48 hours before the refill or renewal period to avoid the next charge.[6]
What if the doctor will not prescribe anything?
At Interlude, the medication fee is refunded and the $45 consultation fee is kept. At Wisp, the company says you are charged a fee of up to $25 instead of the full consult price if no treatment can be prescribed.[14][4]
How long does vaginal estrogen take to work?
The Menopause Society says improvement usually occurs within a few weeks or months with consistent use. Interlude says some improvement may begin within two to four weeks and full benefit may take up to three months. If symptoms are not improving or are getting worse, contact a clinician rather than increasing the dose yourself.[22][8]
Can I use vaginal estrogen if I already use systemic HRT?
Sometimes. The Menopause Society notes that systemic estrogen used for hot flashes can help local symptoms, but some women still benefit from added low-dose vaginal treatment. The decision depends on your current regimen, symptoms, uterus status, and history.[22]
Is compounded estradiol cream the same as an FDA-approved version?
No. The FDA says compounded drugs are not FDA-approved and are not reviewed before marketing for safety, effectiveness, or quality. Interlude's compounded Soothing Estradiol Cream is a different concentration and formulation from its FDA-approved generic 0.01% cream.[16][10]
Does either company sell an estradiol vaginal ring?
Neither company's current verified product pages advertise a vaginal ring. That matters because Estring was the only topical vaginal estrogen in the FDA's first February 2026 labeling-update group.[18]
Does either company order lab tests?
Neither public product flow advertises a routine lab bundle for this care. That does not mean a clinician can never request testing. The more important limitation is that neither service includes a physical examination.
Do I need progesterone with vaginal estrogen?
Low-dose vaginal estrogen is not handled the same way as systemic estrogen. The Menopause Society's GSM position statement says a progestogen is not indicated with low-dose vaginal estrogen, while also noting that endometrial safety beyond one year was not established in clinical trials covered by that statement. Unexplained postmenopausal bleeding must be evaluated. The same label-and-guideline distinction is covered in our vaginal estrogen guide.[23][20]
What states are Wisp and Interlude available in?
Both advertise nationwide access. Wisp says it is available and ships in all 50 states; Interlude advertises all-50-state availability and says a clinician licensed in your state reviews the case. Confirm current eligibility before paying because state-specific telehealth requirements can affect the visit format.[4][13]
Is Wisp's $20 cream FDA-approved?
The public Wisp page does not say. It calls the product prescription estradiol vaginal cream but does not publish the exact formulation, strength, manufacturer, NDC, or FDA status. Do not label it FDA-approved or compounded until Wisp, checkout, the prescription, or the dispensing pharmacy identifies the product.[1]
Why does Interlude show different insert prices?
Its homepage displays “starting at $89,” while the current product page shows $109 with $129 crossed out. The public pages do not explain the difference. Treat the final checkout total as authoritative and screenshot it.[7][9]
What should you do next?
Answer: Sort the symptom lane first, then compare the same product across all four payment routes, then capture the exact checkout terms. That sequence prevents a low headline price from hiding a different product, refill schedule, or cancellation deadline.
- Sort your symptoms. Local only, systemic too, or a red flag that needs an exam?
- Pick the form, then price all four routes. Wisp shipped, Wisp pharmacy, Interlude shipped, or Interlude transfer-out.
- Read the total and product details before entering a card. Strength, quantity, FDA or compounded status, renewal amount, and cancel-by date are the numbers that matter — not the ad.
By The HRT Index Editorial Team · Last verified August 2026 · This page is editorial research and has not been reviewed by a clinician. It is educational and is not medical advice.
How this page is funded: Clearly labeled Wisp and Sesame CTAs on this page may generate a commission at no extra cost. Interlude and Midi links are direct editorial links, and ordinary Wisp research citations remain direct links. Our verdict was determined from the verified evidence above, not from payout. See our affiliate disclosure.
Still not sure which HRT program is right for you? → Use Find My HRT Path for a personalized starting-point plan
Which sources support this comparison?
Answer: Commercial facts come from current provider pages and policies; medical and regulatory claims come from FDA, DailyMed, The Menopause Society, AUA, and NIDDK sources. Each source below is dated to the verification pass used for this article.
1 Wisp — Estradiol Vaginal Cream. Starting price, one-time/subscription choice, eligibility wording, latex-condom warning, local pickup, and public product disclosures. Accessed August 12, 2026.
2 Wisp — Pricing. Consult inclusion, HSA/FSA, all-50-state shipping, local-pharmacy insurance, and GoodRx route. Accessed August 12, 2026.
3 Wisp — Menopause Consult Online. $99 consult, three-month Care Team access, medication paid separately, systemic estradiol/progesterone options, and all-50-state claim. Accessed August 12, 2026.
4 Wisp — How It Works. Clinician-review flow, up-to-$25 declined-treatment fee, provider messaging, nationwide claim, and pharmacy routing. Accessed August 12, 2026.
5 Wisp — FAQ. LegitScript display, support topics, and prescription-flow disclosures. Accessed August 12, 2026.
6 Wisp — Terms of Service. Updated May 6, 2026; final-sale exceptions, charge review, and 48-hour subscription-cancellation requirement. Accessed August 12, 2026.
7 Interlude — Homepage. Current “starting at” product prices and product catalog. Accessed August 12, 2026.
8 Interlude — Estradiol Vaginal Cream. 0.01%, 42.5 g, FDA-approved generic disclosure, $39/$59 pricing, supply length, dosing, process, and 6-vs-7 refill wording. Accessed August 12, 2026.
9 Interlude — Estradiol Vaginal Suppositories. 10 mcg, 18 inserts, two-month claim, $109/$129 product-page pricing, dosing, FDA-approved generic disclosure, and 6-vs-7 refill wording. Accessed August 12, 2026.
10 Interlude — Soothing Estradiol Cream. 30 g tube, 0.003% estradiol, additives, 503A/PCAB disclosure, $49/$69 pricing, and dosing. Accessed August 12, 2026.
11 Interlude — Pricing. One-time consult structure, refill period, shipping, and declined-patient refund wording. Accessed August 12, 2026.
12 Interlude — FAQ. Updated February 10, 2025; clinician timing, HSA/FSA, insurance, transfers, automatic shipments, cancellation path, early refill, and six-refill wording. Accessed August 12, 2026.
13 Interlude — How It Works. Checkout-before-assessment sequence, clinician review, state licensure, shipping, acute local pickup, and no incoming transfers. Accessed August 12, 2026.
14 Interlude — Refunds and Returns. Updated February 12, 2025; medication-fee refund, nonrefundable consult, prescription refund limits, defective-product window, and two-day deadline. Accessed August 12, 2026.
15 Interlude — Terms of Service. Automatic two-month subscription structure, price-change language, and two-business-day cancellation term. Accessed August 12, 2026.
16 FDA — Compounding and the FDA: Questions and Answers. Compounded-versus-FDA-approved distinction and FDA premarket-review status. Accessed August 12, 2026.
17 FDA — Generic Drugs: Questions & Answers. FDA standards for generic strength, dosage form, route, quality, labeling, and bioequivalence. Updated June 8, 2026; accessed August 12, 2026.
18 FDA — Menopausal Hormone Therapies with Updated Prescribing Information and FDA press announcement, February 12, 2026. First six updated products and Estring's placement in the topical-vaginal category. Accessed August 12, 2026.
19 FDA — Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms. Systemic and topical-vaginal therapy categories. Published February 13, 2026.
20 DailyMed — Estradiol Vaginal Cream, USP 0.01%. Current boxed warning and bleeding language. Accessed August 12, 2026.
21 DailyMed — Estradiol Vaginal Insert 10 mcg. Current boxed warning and one-daily-for-two-weeks, then twice-weekly dosing. Accessed August 12, 2026.
22 The Menopause Society — Genitourinary Syndrome of Menopause MenoNote. Local-versus-systemic treatment, typical dosing forms, expected time to improvement, cancer-history collaboration, and exam-worthy alternative causes. May 2025.
23 The Menopause Society — 2020 Genitourinary Syndrome of Menopause Position Statement. Progestogen guidance for low-dose vaginal estrogen and the stated limit of endometrial-safety trial data beyond one year. Published 2020; accessed August 12, 2026.
24 American Urological Association — Recurrent Uncomplicated Urinary Tract Infections in Women Guideline. Vaginal-estrogen recommendation for peri- and postmenopausal women with recurrent UTIs. Accessed August 12, 2026.
25 Drugs.com — Estradiol Topical Price Guide. 42.5 g cream and 8-/18-count insert cash-price benchmarks and pricing disclaimer. Accessed August 12, 2026.
26 GoodRx — How Much Is Vagifem Without Insurance?. Published example of 8 generic 10 mcg estradiol vaginal tablets from $37.83; coupon pricing varies by pharmacy, location, quantity, and date. Accessed August 12, 2026.
27 NIDDK — Symptoms and Causes of Kidney Infection. Fever, urinary symptoms, and back/side/groin pain red flags. Accessed August 12, 2026.
28 Midi Health — Pricing & Insurance and How Midi Works. Nationwide access, PPO network statement, Medicare self-pay/no-claims rule, and Medicaid/Medi-Cal restriction. Accessed August 12, 2026.
29 Inner Balance — Oestra Product Page. Prescription vaginal cream containing estradiol and progesterone; compounded in a licensed pharmacy. Accessed August 12, 2026.
30 The HRT Index — Affiliate Disclosure. Active Wisp affiliate relationship and the distinction between labeled affiliate links and direct editorial links. Updated July 6, 2026; accessed August 12, 2026.
31 Sesame — Women's Health, OB/GYN listings, and Terms of Service. Upfront cash pricing, in-person/video appointment marketplace, and federal-health-care-program beneficiary restriction. Accessed August 12, 2026.
